# FDA Inspection 1133295 - David S. Siegel, M.D. - November 02, 2020

Source: https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/4b38d521-79bd-44e0-8335-174e2e31cccf
Source feed: FDA_Inspections

> FDA Inspection 1133295 for David S. Siegel, M.D. on November 02, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1133295
- Company Name: David S. Siegel, M.D.
- Inspection Date: 2020-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1133295 - 2020-11-02](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/e20125f5-3cce-492f-ad97-a0c80551c771)
- [FDA Inspection 944842 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/b43f7930-3df3-49f3-8b24-8211ee01a289)
- [FDA Inspection 791988 - 2012-07-25](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/69a19cec-8ec9-45a0-9b46-db97b51007b3)
- [FDA Inspection 767213 - 2012-01-27](https://www.keypedia.com/records/fda_inspections/david-s-siegel-md/e50b3dd6-bb93-43b3-a624-9f39fd27a1bd)

Company: https://www.keypedia.com/companies/david-s-siegel-md/8396ffc1-7d13-4e50-8060-8e3faa29a296

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d